Clinical Trial Update: KW-6002 to Treat Parkinson's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for KW-6002 (istradefylline) in Parkinson's disease indicates the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• istradefylline (istradefylline)

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED